Search...
Key facts: GSK Buyback Reaches 237M Shares; CDC Talks Impact Vaccines
I'm PortAI, I can summarize articles.
On December 4, 2025, GSK plc bought 11,764,733 shares in its buyback program, raising total treasury shares to 237,229,577, which is 5.82% of voting rights.1GSK, with Merck, makes hepatitis B vaccines. Recent CDC ACIP talks on vaccination schedules could impact GSK's vaccine supply and distribution.2
- On December 4, 2025, GSK plc bought 11,764,733 shares in its buyback program, raising total treasury shares to 237,229,577, which is 5.82% of voting rights.1
- GSK, with Merck, makes hepatitis B vaccines. Recent CDC ACIP talks on vaccination schedules could impact GSK's vaccine supply and distribution.2
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments